XM1285 Medical Treatment
Initial Operational Capability (IOC):
Also Known As: AMPV Medical Treatment and Armored Multi-Purpose Vehicle
Origin: United States of America
Air Methods Corporation, BAE Systems*, DRS Technologies and Northrop Grumman (*) lead contractor
There are no reviews so far
Description: The US Army's Armored Multi-Purpose Vehicle (AMPV) is a family of medium armored vehicles intended as the replacement for the Vietnam-era M113 tracked armored personnel carrier and its variants. The new vehicle family is expected to be far more survivable and mobile than the M113s utilizing the M2 Bradley chassis. BAE Systems was awarded a 52-month $383 million contract for the Engineering, Manufacturing, and Development (EMD) phase of the AMPV program on December 23, 2014. Five variants are envisaged at this stage of the program: General Purpose, Mission Command, Mortar Carrier, Medical Evacuation and Medical Treatment. The EMD phase will be completed by 2019 and the new AMPV vehicles may achieve initial operational capability by 2020 or later.
The US Army's AMPV Medical Treatment is a mobile hospital variant to provide medical relief to wounded troops.
Copyright © 2003-2019 deagel.com website. All rights reserved.